evidence: Karatas M, Tatar E, Simsek C, Yıldırım AM, Ari A, Zengel B, et al. Covid-19 pneumonia in kidney transplant recipients: A promising treatment algorithm in the absence of a disease-specific drug. J Med Virol (2021) 93(No.10):5789–97. doi: 10.1002/jmv.27110 7. Momi S, Canino J, Vismara M, Galgano L, Falcinelli E, Guglielmini G, et al. Proline-rich tyrosine kinase pyk2 regulates deep vein thrombosis. Haematologica (2022) 107(No.6):1374–83. doi: 10.3324/haematol.2021.279703 8. Merad M, Martin JC. Pathological inflammation in patients with covid-19: A key role for monocytes and macrophages. Nat Rev Immunol (2020) 20(6):355–62. doi: 10.1038/s41577-020-0331-4 9. Whyte CS, Mostefai HA, Baeten KM, Lucking AJ, Newby DE, Booth NA, et al. Role of shear stress and tpa concentration in the fibrinolytic potential of thrombi. Int J Mol Sci (2021) 22(No.4):2115. doi: 10.3390/ijms22042115 10. Wu H, Wang Y, Zhang Y, Xu F, Chen J, Duan L, et al. Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting lps-induced inflammation and oxidative stress. Redox Biol (2020) 32:101500. doi: 10.1016/j.redox.2020.101500 11.